Home - Products - Angiogenesis - EGFR - (1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine

(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine

CAS No. 146504-07-6

(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine( —— )

Catalog No. M18038 CAS No. 146504-07-6

Cyclohexanediamine has a potential of anticancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 45 In Stock
25MG 63 In Stock
50MG 90 In Stock
100MG 120 In Stock
200MG 168 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyclohexanediamine has a potential of anticancer activity.
  • Description
    Cyclohexanediamine has a potential of anticancer activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    146504-07-6
  • Formula Weight
    214.31
  • Molecular Formula
    C11H22N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C)OC(=O)N[C@@H]1CCCC[C@H]1N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • EAI001

    EAI001 is a potent and selective mutant epidermal growth factor receptor (EGFR) variant inhibitor that inhibits EGFRL858R/T790M with an IC50 value of 24 nM.EAI001 can be used in cancer research.

  • OBX02-011

    OBX02-011 is an effective and reversible inhibitor of EGFR tyrosine kinase with IC50s of 0.134 and 2.09 nM for triple mutants Del19/T790M/C797S and L858R/T790M/C797S.

  • PF-06747775

    A potent, selective, irreversible EGFR mutants with IC50 of 12, 3, 4 and 5 nM for EGFR L858R-T790M, Del-T790M, L858R, and EGFR Del, respectively.